All terms in BAO
| Label | Id | Description |
|---|---|---|
| condensed | PATO_0001485 | [A structural quality inhering in a bearer by virtue of the bearer's being thicker or more closely packed together; pressed tightly together.] |
| small intestine cancer | DOID_10154 | [An intestinal cancer that is located_in the small intestine.] |
| small intestine adenocarcinoma | DOID_4906 | [A small intestine carcinoma that derives_from epithelial cells of glandular origin.] |
| anal carcinoma | DOID_4908 | [A anus cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells and is located_in the anus.] |
| anus cancer | DOID_14110 | [A large intestine cancer that is located_in the anus.] |
| semiochemical | CHEBI_26645 | |
| eosinophilic esophagitis | DOID_13922 | [An esophagitis characterized by inflammation involving eosinophils located_in esophagus.] |
| esophagitis | DOID_11963 | |
| Papio hamadryas metabolite | CHEBI_137684 | |
| lacrimal duct obstruction | DOID_13929 | |
| phytoestrogen | CHEBI_76989 | |
| EC 1.4.3.4 (monoamine oxidase) inhibitor | CHEBI_38623 | |
| EC 1.4.3.* (oxidoreductase acting on donor CH-NH2 group, oxygen as acceptor) inhibitor | CHEBI_76861 | |
| xenoestrogen | CHEBI_76988 | |
| endocrine disruptor | CHEBI_138015 | |
| apoptosis inducer | CHEBI_68495 | |
| apoptosis inhibitor | CHEBI_68494 | |
| mycoestrogen | CHEBI_76990 | |
| positive regulation of lipid storage | GO_0010884 | [Any process that increases the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development.] |
| acute leukemia | DOID_12603 | [A leukemia that occurs when a hematopoietic stem cell undergoes malignant transformation into a primitive, undifferentiated cell with abnormal longevity. These lymphocytes (acute lymphocytic leukemia [ALL]) or myeloid cells (acute myelocytic leukemia [AML]) proliferate abnormally, replacing normal marrow tissue and hematopoietic cells and inducing anemia, thrombocytopenia, and granulocytopenia.] |